Recent VIRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2025 10:00:32 PM
- Viracta Therapeutics Announces Wind Down of Operations • GlobeNewswire Inc. • 02/05/2025 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:30:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2025 10:14:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2025 09:08:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:39:52 PM
- Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 12/26/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 10:14:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 09:06:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2024 10:20:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 12:30:08 PM
- Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:46:38 PM
- Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma • GlobeNewswire Inc. • 11/06/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 10:10:04 PM
- Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:15:25 AM
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 11:05:00 AM
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan • GlobeNewswire Inc. • 08/14/2024 11:00:00 AM
FEATURED MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness • Jun 24, 2025 8:45 AM
FEATURED Envirotech (EVTV) Announces Vision for Multi-modal Electric Mobility Ecosystem • Jun 24, 2025 8:42 AM
Avant Technologies Creating New Company for Expansion of Diabetes Program • AVAI • Jun 24, 2025 8:00 AM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM